Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
Hellwig D, Ketter R, Romeike BF, Schaefer A, Farmakis G, Grgic A, et al. Prospective study of p-[(123)I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma. Eur J Nucl Med Mol Imaging 2010. doi:10.​1007/​s00259-010-1572-4.
2.
Fotopoulos AD, Kyritsis AP, Tsiouris S, Al-Boucharali J, Papadopoulos A, Voulgaris S, et al. Characterization of intracranial space-occupying lesions by (99 m)Tc-tetrofosmin SPECT. J Neurooncol 2010. Epub ahead of print.
3.
Alexiou GA, Tsiouris S, Goussia A, Papadopoulos A, Kyritsis AP, Polyzoidis KS, et al. Evaluation of glioma proliferation by 99mTc-tetrofosmin. Neuro Oncol 2008;10:104–5.CrossRefPubMed
4.
Alexiou GA, Tsiouris S, Vartholomatos G, Fotakopoulos G, Papadopoulos A, Kyritsis AP, et al. Correlation of glioma proliferation assessed by flow cytometry with (99m)Tc-tetrofosmin SPECT uptake. Clin Neurol Neurosurg 2009;111:808–11.CrossRefPubMed
5.
Alexiou GA, Goussia A, Kyritsis AP, Tsiouris S, Ntoulia A, Malamou-Mitsi V, et al. Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake. Mol Imaging Biol 2010. Epub ahead of print.
Metadata
Title
99mTc-Tetrofosmin SPECT for the evaluation of cerebral lesions
Authors
George A. Alexiou
Andreas D. Fotopoulos
Spyridon Tsiouris
Spyridon Voulgaris
Athanasios P. Kyritsis
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2010
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-010-1602-2

Other articles of this Issue 12/2010

European Journal of Nuclear Medicine and Molecular Imaging 12/2010 Go to the issue

Guidelines

131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging

Original Article

18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer

Focus On...

PET, CT and MRI characterisation of the atherosclerotic plaque

Original Article

Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism

Original Article

Detection of respiratory tumour motion using intrinsic list mode-driven gating in positron emission tomography

Original Article

Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma